| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.24e-05 | 2 | 145 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.24e-05 | 2 | 145 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.56e-04 | 3 | 145 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.60e-04 | 15 | 145 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.61e-04 | 129 | 145 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 STIM2 PCDHA8 EFCAB14 DNAH7 RYR3 ITPR1 CAPN13 SNED1 FBN1 EGF MEGF6 LTBP3 NOTCH3 OC90 | 3.68e-04 | 749 | 145 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 5.11e-04 | 51 | 145 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 6.82e-04 | 55 | 145 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.30e-04 | 151 | 145 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 9.19e-04 | 343 | 145 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 9.49e-04 | 60 | 145 | 4 | GO:0034212 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A4 HSPG2 LRRN1 FCN3 SNED1 FBN1 PXDN MEGF6 CCN2 LTBP3 PLG MUC2 SCARA3 OC90 | 2.09e-04 | 656 | 146 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A4 HSPG2 LRRN1 FCN3 SNED1 FBN1 PXDN MEGF6 CCN2 LTBP3 PLG MUC2 SCARA3 OC90 | 2.15e-04 | 658 | 146 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | kinetochore | 2.87e-04 | 181 | 146 | 7 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 4.22e-04 | 193 | 146 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | intercellular bridge | 5.17e-04 | 94 | 146 | 5 | GO:0045171 | |
| HumanPheno | Elbow dislocation | 7.69e-07 | 84 | 64 | 9 | HP:0003042 | |
| HumanPheno | Abnormality of the elbow | HSPG2 APC CHD7 CREBBP FBN1 LMX1B POP1 RSPO2 LTBP3 HEPHL1 FZD2 EP300 UNC80 KIF22 PCNT | 1.32e-06 | 282 | 64 | 15 | HP:0009811 |
| HumanPheno | Upper extremity joint dislocation | 2.41e-06 | 96 | 64 | 9 | HP:0030310 | |
| HumanPheno | Aplasia involving bones of the extremities | RAD51 SOX11 HSPG2 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 ITPR1 FBN1 LMX1B POP1 FGD1 RSPO2 LTBP3 HERC2 HEPHL1 FZD2 EP300 UNC80 KIF22 PCNT | 6.65e-06 | 759 | 64 | 24 | HP:0009825 |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | RAD51 SOX11 HSPG2 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 ITPR1 FBN1 LMX1B POP1 FGD1 RSPO2 LTBP3 HERC2 HEPHL1 FZD2 EP300 UNC80 KIF22 PCNT | 6.96e-06 | 761 | 64 | 24 | HP:0045060 |
| HumanPheno | Abnormal morphology of bones of the lower limbs | RAD51 HSPG2 TRPS1 CHD7 CREBBP PALB2 ITPR1 FBN1 LMX1B POP1 SCN9A LTBP3 HEPHL1 FZD2 EP300 KIF22 PCNT | 1.06e-05 | 422 | 64 | 17 | HP:0040066 |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 1.40e-05 | 150 | 64 | 10 | HP:0009601 | |
| HumanPheno | Keloids | 1.49e-05 | 13 | 64 | 4 | HP:0010562 | |
| HumanPheno | Abnormal femur morphology | RAD51 HSPG2 TRPS1 CHD7 CREBBP PALB2 FBN1 LMX1B POP1 LTBP3 FZD2 EP300 KIF22 PCNT | 1.70e-05 | 304 | 64 | 14 | HP:0002823 |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | RAD51 SOX11 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 FGD1 RSPO2 LTBP3 HERC2 FZD2 EP300 UNC80 KIF22 PCNT | 1.88e-05 | 538 | 64 | 19 | HP:0005927 |
| HumanPheno | Aplasia/hypoplasia of the extremities | RAD51 SOX11 HSPG2 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 ITPR1 FBN1 LMX1B POP1 FGD1 RSPO2 LTBP3 HERC2 HEPHL1 FZD2 EP300 UNC80 KIF22 PCNT | 2.21e-05 | 813 | 64 | 24 | HP:0009815 |
| HumanPheno | Abnormality of upper limb joint | HSPG2 SEPTIN9 TRPS1 APC CHD7 CREBBP RYR3 ITPR1 FBN1 LMX1B POP1 FGD1 RSPO2 AKT1 CCN2 LTBP3 HEPHL1 FZD2 EP300 UNC80 KIF22 PCNT | 2.39e-05 | 705 | 64 | 22 | HP:0009810 |
| HumanPheno | Abnormal long bone morphology | RAD51 HSPG2 TRPS1 APC CHD7 LRRK1 CREBBP PALB2 ITPR1 FBN1 LMX1B POP1 SCN9A RSPO2 AKT1 PISD LTBP3 HERC2 HEPHL1 FZD2 EP300 NOTCH3 KIF22 PCNT | 2.62e-05 | 821 | 64 | 24 | HP:0011314 |
| HumanPheno | Short long bone | RAD51 HSPG2 TRPS1 APC CHD7 PALB2 ITPR1 FBN1 LTBP3 HEPHL1 FZD2 EP300 PCNT | 3.06e-05 | 278 | 64 | 13 | HP:0003026 |
| HumanPheno | Aplasia/Hypoplasia of fingers | RAD51 SOX11 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 FGD1 RSPO2 FZD2 EP300 PCNT | 3.24e-05 | 366 | 64 | 15 | HP:0006265 |
| HumanPheno | Abnormality of the thigh | RAD51 HSPG2 TRPS1 CHD7 CREBBP PALB2 FBN1 LMX1B POP1 LTBP3 FZD2 EP300 KIF22 PCNT | 3.26e-05 | 322 | 64 | 14 | HP:0001439 |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 4.02e-05 | 52 | 64 | 6 | HP:0009834 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | RAD51 SOX11 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 FGD1 RSPO2 LTBP3 HERC2 FZD2 EP300 UNC80 KIF22 PCNT | 4.49e-05 | 572 | 64 | 19 | HP:0006496 |
| HumanPheno | Abnormality of the dentition | RAD51 SOX11 HSPG2 WNT10B TRPS1 APC CHD7 CREBBP ITPR1 FBN1 KRT71 LMX1B POP1 FGD1 AKT1 CACNA1I CCN2 LTBP3 HERC2 PLG HEPHL1 FTO FZD2 EP300 NOTCH3 PCNT WDR72 | 4.71e-05 | 1030 | 64 | 27 | HP:0000164 |
| HumanPheno | Dislocated radial head | 5.00e-05 | 54 | 64 | 6 | HP:0003083 | |
| HumanPheno | Abnormality of the radial head | 6.82e-05 | 57 | 64 | 6 | HP:0003995 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 8.71e-05 | 86 | 64 | 7 | HP:0006499 | |
| HumanPheno | Full cheeks | 9.52e-05 | 151 | 64 | 9 | HP:0000293 | |
| HumanPheno | Abnormality of the humeroradial joint | 1.10e-04 | 62 | 64 | 6 | HP:0100744 | |
| HumanPheno | Narrow mouth | HSPG2 SEPTIN9 APC CHD7 CREBBP FBN1 LMX1B RSPO2 AKT1 LTBP3 EP300 | 1.30e-04 | 234 | 64 | 11 | HP:0000160 |
| HumanPheno | Abnormal femoral head morphology | 1.34e-04 | 92 | 64 | 7 | HP:0003368 | |
| HumanPheno | Abnormal metatarsal morphology | 1.42e-04 | 159 | 64 | 9 | HP:0001832 | |
| HumanPheno | Pilomatrixoma | 1.51e-04 | 9 | 64 | 3 | HP:0030434 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.53e-04 | 94 | 64 | 7 | HP:0006500 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.55e-04 | 2 | 64 | 2 | HP:0034227 | |
| HumanPheno | Plantar crease between first and second toes | 1.55e-04 | 2 | 64 | 2 | HP:0008107 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 1.55e-04 | 2 | 64 | 2 | HP:0005900 | |
| HumanPheno | High axial triradius | 1.55e-04 | 2 | 64 | 2 | HP:0001042 | |
| HumanPheno | Abnormal cheek morphology | SOX11 HSPG2 CHD7 PSPH CREBBP ZNF462 FBN1 LMX1B FGD1 LTBP3 EP300 PCNT | 1.61e-04 | 282 | 64 | 12 | HP:0004426 |
| HumanPheno | Clinodactyly | RAD51 SOX11 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 HERC2 HEPHL1 FZD2 EP300 EPB41L1 PCNT | 1.61e-04 | 574 | 64 | 18 | HP:0030084 |
| HumanPheno | Short thumb | 1.64e-04 | 127 | 64 | 8 | HP:0009778 | |
| HumanPheno | Juvenile aseptic necrosis | 1.78e-04 | 43 | 64 | 5 | HP:0100323 | |
| HumanPheno | Abnormal lower limb bone morphology | RAD51 HSPG2 WNT10B TRPS1 APC CHD7 CREBBP PALB2 ITPR1 FBN1 LMX1B POP1 SCN9A FGD1 AKT1 LTBP3 HERC2 HEPHL1 FZD2 EP300 EPB41L1 KIF22 PCNT | 1.93e-04 | 866 | 64 | 23 | HP:0040069 |
| HumanPheno | Sleep-related breathing disorders | 2.25e-04 | 169 | 64 | 9 | HP:5200283 | |
| HumanPheno | Abnormal upper limb bone morphology | RAD51 TRPS1 APC CHD7 CREBBP PALB2 FBN1 LMX1B SCN9A RSPO2 AKT1 LTBP3 FZD2 EP300 KIF22 PCNT | 2.25e-04 | 484 | 64 | 16 | HP:0040070 |
| HumanPheno | Abnormal morphology of bones of the upper limbs | RAD51 TRPS1 APC CHD7 CREBBP PALB2 FBN1 LMX1B RSPO2 AKT1 LTBP3 FZD2 EP300 KIF22 PCNT | 2.40e-04 | 436 | 64 | 15 | HP:0040065 |
| HumanPheno | Abnormal midface morphology | SOX11 HSPG2 APC TSEN54 CHD7 PSPH CREBBP ZNF462 FBN1 LMX1B POP1 FGD1 AKT1 LTBP3 FZD2 EP300 EPB41L1 NOTCH3 KIF22 PCNT | 2.45e-04 | 704 | 64 | 20 | HP:0000309 |
| HumanPheno | Joint dislocation | RAD51 HSPG2 TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 LMX1B AKT1 FZD2 EP300 KIF22 | 2.60e-04 | 390 | 64 | 14 | HP:0001373 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | HSPG2 WNT10B TRPS1 APC CHD7 ITPR1 FBN1 FGD1 LTBP3 HERC2 HEPHL1 EP300 | 2.70e-04 | 298 | 64 | 12 | HP:0006494 |
| HumanPheno | Abnormal hip bone morphology | RAD51 HSPG2 TRPS1 APC CREBBP PALB2 RYR3 FBN1 LMX1B POP1 SCN9A AKT1 CCN2 HERC2 FZD2 EP300 UNC80 KIF22 PCNT | 2.71e-04 | 653 | 64 | 19 | HP:0003272 |
| HumanPheno | Deep philtrum | 3.17e-04 | 75 | 64 | 6 | HP:0002002 | |
| HumanPheno | Abnormal hand morphology | RAD51 SOX11 HSPG2 AFF2 WNT10B TRPS1 APC CHD7 CREBBP PALB2 RYR3 ZNF462 FBN1 LMX1B SCN9A FGD1 RSPO2 AKT1 LTBP3 HERC2 FZD2 EP300 UNC80 EPB41L1 KIF22 PCNT | 3.20e-04 | 1082 | 64 | 26 | HP:0005922 |
| HumanPheno | Abnormal morphology of the radius | 3.21e-04 | 217 | 64 | 10 | HP:0002818 | |
| HumanPheno | Radial deviation of finger | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 HERC2 FZD2 EP300 PCNT | 3.23e-04 | 448 | 64 | 15 | HP:0009466 |
| HumanPheno | Finger clinodactyly | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 FZD2 EP300 EPB41L1 PCNT | 3.56e-04 | 452 | 64 | 15 | HP:0040019 |
| HumanPheno | Abnormal scrotum morphology | 3.71e-04 | 143 | 64 | 8 | HP:0000045 | |
| HumanPheno | Brachydactyly | SOX11 HSPG2 TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 POP1 FGD1 AKT1 LTBP3 FTO FZD2 EP300 EPB41L1 KIF22 PCNT | 3.79e-04 | 670 | 64 | 19 | HP:0001156 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 HERC2 FZD2 EP300 PCNT | 3.91e-04 | 456 | 64 | 15 | HP:0009485 |
| HumanPheno | Short digit | SOX11 HSPG2 TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 POP1 FGD1 AKT1 LTBP3 FTO FZD2 EP300 EPB41L1 KIF22 PCNT | 3.94e-04 | 672 | 64 | 19 | HP:0011927 |
| HumanPheno | Abnormal pelvic girdle bone morphology | RAD51 HSPG2 TRPS1 APC CREBBP PALB2 RYR3 FBN1 LMX1B POP1 SCN9A RSPO2 AKT1 CCN2 HERC2 FZD2 EP300 UNC80 KIF22 PCNT | 4.00e-04 | 730 | 64 | 20 | HP:0002644 |
| HumanPheno | Abnormality of the helix | 4.09e-04 | 183 | 64 | 9 | HP:0000380 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 RYR3 ZNF462 LMX1B FGD1 AKT1 HERC2 FZD2 EP300 EPB41L1 PCNT | 4.16e-04 | 564 | 64 | 17 | HP:0009484 |
| HumanPheno | Laryngeal cartilage malformation | 4.62e-04 | 3 | 64 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 4.62e-04 | 3 | 64 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 4.62e-04 | 3 | 64 | 2 | HP:0000756 | |
| HumanPheno | Abnormal upper to lower segment ratio | 4.62e-04 | 3 | 64 | 2 | HP:0012772 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 4.62e-04 | 3 | 64 | 2 | HP:0005895 | |
| HumanPheno | Humoral immunodeficiency | 4.62e-04 | 3 | 64 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 4.62e-04 | 3 | 64 | 2 | HP:0005322 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 4.86e-04 | 30 | 64 | 4 | HP:0005743 | |
| HumanPheno | Abnormality of the tubular bones | RAD51 HSPG2 TRPS1 APC CHD7 CREBBP PALB2 ITPR1 FBN1 RSPO2 AKT1 LTBP3 HERC2 HEPHL1 FZD2 EP300 KIF22 PCNT | 5.40e-04 | 632 | 64 | 18 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | RAD51 HSPG2 TRPS1 APC CHD7 CREBBP PALB2 ITPR1 FBN1 RSPO2 AKT1 LTBP3 HERC2 HEPHL1 FZD2 EP300 KIF22 PCNT | 5.40e-04 | 632 | 64 | 18 | HP:0100714 |
| HumanPheno | Abnormality of the epiphysis of the femoral head | 5.50e-04 | 83 | 64 | 6 | HP:0010574 | |
| HumanPheno | Clinodactyly of the 5th finger | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 FZD2 EP300 PCNT | 5.57e-04 | 420 | 64 | 14 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 FZD2 EP300 PCNT | 5.71e-04 | 421 | 64 | 14 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 FZD2 EP300 PCNT | 5.71e-04 | 421 | 64 | 14 | HP:0009179 |
| HumanPheno | Abnormal number of teeth | RAD51 HSPG2 WNT10B TRPS1 APC CHD7 CREBBP POP1 FGD1 AKT1 LTBP3 FZD2 EP300 PCNT | 5.71e-04 | 421 | 64 | 14 | HP:0006483 |
| HumanPheno | Laryngomalacia | 5.86e-04 | 84 | 64 | 6 | HP:0001601 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | HSPG2 WNT10B TRPS1 APC CHD7 ITPR1 FBN1 LMX1B POP1 FGD1 LTBP3 HERC2 HEPHL1 FZD2 EP300 | 5.93e-04 | 474 | 64 | 15 | HP:0006493 |
| HumanPheno | Short finger | SOX11 TRPS1 APC CHD7 CREBBP PALB2 RYR3 FBN1 FGD1 FZD2 EP300 PCNT | 5.98e-04 | 325 | 64 | 12 | HP:0009381 |
| HumanPheno | Abnormal epiphysis morphology | HSPG2 TRPS1 CREBBP FBN1 SCN9A PISD LTBP3 FZD2 EP300 KIF22 PCNT | 6.02e-04 | 279 | 64 | 11 | HP:0005930 |
| HumanPheno | Congenital malformation of the great arteries | RAD51 SOX11 HSPG2 CHD7 CREBBP PALB2 ITPR1 ZNF462 RSPH3 FBN1 LMX1B CFAP74 FTO EP300 NOTCH3 PCNT | 6.20e-04 | 529 | 64 | 16 | HP:0011603 |
| HumanPheno | Supernumerary tooth | 6.25e-04 | 85 | 64 | 6 | HP:0011069 | |
| HumanPheno | Abnormal forearm bone morphology | 6.27e-04 | 236 | 64 | 10 | HP:0040072 | |
| HumanPheno | Abnormal forearm morphology | 6.92e-04 | 239 | 64 | 10 | HP:0002973 | |
| HumanPheno | Hypoplastic facial bones | HSPG2 APC CHD7 CREBBP FBN1 FGD1 AKT1 LTBP3 FZD2 EP300 NOTCH3 KIF22 | 7.05e-04 | 331 | 64 | 12 | HP:0002692 |
| HumanPheno | Aplasia/Hypoplasia of facial bones | HSPG2 APC CHD7 CREBBP FBN1 FGD1 AKT1 LTBP3 FZD2 EP300 NOTCH3 KIF22 | 7.24e-04 | 332 | 64 | 12 | HP:0034261 |
| HumanPheno | Deviation of finger | RAD51 HSPG2 AFF2 TRPS1 CHD7 CREBBP PALB2 ZNF462 LMX1B FGD1 AKT1 HERC2 FZD2 EP300 EPB41L1 PCNT | 7.32e-04 | 537 | 64 | 16 | HP:0004097 |
| HumanPheno | Abnormal larynx morphology | 8.10e-04 | 201 | 64 | 9 | HP:0025423 | |
| HumanPheno | Abnormal femoral neck/head morphology | 8.10e-04 | 201 | 64 | 9 | HP:0003366 | |
| HumanPheno | Abnormal hip joint morphology | RAD51 HSPG2 TRPS1 APC CREBBP PALB2 RYR3 FBN1 AKT1 HERC2 FZD2 EP300 UNC80 KIF22 PCNT | 8.42e-04 | 490 | 64 | 15 | HP:0001384 |
| HumanPheno | Trichiasis | 9.17e-04 | 4 | 64 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 9.17e-04 | 4 | 64 | 2 | HP:0410266 | |
| HumanPheno | Widened distal phalanges | 9.17e-04 | 4 | 64 | 2 | HP:0006200 | |
| HumanPheno | Hepatic hemangioma | 9.17e-04 | 4 | 64 | 2 | HP:0031207 | |
| HumanPheno | Talipes calcaneovarus | 9.17e-04 | 4 | 64 | 2 | HP:0008124 | |
| HumanPheno | Talon cusp | 9.17e-04 | 4 | 64 | 2 | HP:0011087 | |
| HumanPheno | Vascular ring | 9.17e-04 | 4 | 64 | 2 | HP:0010775 | |
| HumanPheno | Abnormal facial shape | RAD51 SOX11 HSPG2 SEPTIN9 WNT10B TRPS1 APC TSEN54 CHD7 PSPH CREBBP PALB2 RYR3 ITPR1 FBN1 LMX1B FGD1 AKT1 LTBP3 HEPHL1 FTO FZD2 EP300 UNC80 NOTCH3 KIF22 PCNT | 9.25e-04 | 1221 | 64 | 27 | HP:0001999 |
| HumanPheno | Square face | 9.43e-04 | 16 | 64 | 3 | HP:0000321 | |
| HumanPheno | Short metatarsal | 9.96e-04 | 62 | 64 | 5 | HP:0010743 | |
| HumanPheno | Long eyelashes | 1.06e-03 | 129 | 64 | 7 | HP:0000527 | |
| HumanPheno | Hypoplastic ilia | 1.07e-03 | 63 | 64 | 5 | HP:0000946 | |
| HumanPheno | Sleep apnea | 1.08e-03 | 168 | 64 | 8 | HP:0010535 | |
| HumanPheno | Limited elbow movement | 1.08e-03 | 168 | 64 | 8 | HP:0002996 | |
| MousePheno | abnormal chest morphology | 1.73e-05 | 39 | 117 | 5 | MP:0004134 | |
| MousePheno | abnormal maxilla morphology | 2.76e-05 | 144 | 117 | 8 | MP:0000455 | |
| MousePheno | abnormal uvea morphology | 3.42e-05 | 241 | 117 | 10 | MP:0005197 | |
| MousePheno | absence of all nails | 6.95e-05 | 2 | 117 | 2 | MP:0008494 | |
| MousePheno | impaired long-term object recognition memory | 8.17e-05 | 28 | 117 | 4 | MP:0014367 | |
| MousePheno | abnormal pelvic girdle bone morphology | 8.79e-05 | 87 | 117 | 6 | MP:0004509 | |
| Domain | ZF_ZZ_2 | 8.29e-06 | 18 | 139 | 4 | PS50135 | |
| Domain | ZF_ZZ_1 | 8.29e-06 | 18 | 139 | 4 | PS01357 | |
| Domain | ZZ | 8.29e-06 | 18 | 139 | 4 | PF00569 | |
| Domain | Znf_ZZ | 1.04e-05 | 19 | 139 | 4 | IPR000433 | |
| Domain | ZnF_ZZ | 1.04e-05 | 19 | 139 | 4 | SM00291 | |
| Domain | Growth_fac_rcpt_ | 2.21e-05 | 156 | 139 | 8 | IPR009030 | |
| Domain | Ion_trans_dom | 2.30e-05 | 114 | 139 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.30e-05 | 114 | 139 | 7 | PF00520 | |
| Domain | EGF_CA | 3.57e-05 | 122 | 139 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.96e-05 | 124 | 139 | 7 | IPR001881 | |
| Domain | hEGF | 5.24e-05 | 28 | 139 | 4 | PF12661 | |
| Domain | Nuc_rcpt_coact_CREBbp | 5.50e-05 | 2 | 139 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 5.50e-05 | 2 | 139 | 2 | SM00551 | |
| Domain | - | 5.50e-05 | 2 | 139 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 5.50e-05 | 2 | 139 | 2 | IPR010303 | |
| Domain | - | 5.50e-05 | 2 | 139 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 5.50e-05 | 2 | 139 | 2 | PF09030 | |
| Domain | zf-TAZ | 5.50e-05 | 2 | 139 | 2 | PF02135 | |
| Domain | ZF_TAZ | 5.50e-05 | 2 | 139 | 2 | PS50134 | |
| Domain | KAT11 | 5.50e-05 | 2 | 139 | 2 | SM01250 | |
| Domain | Znf_TAZ | 5.50e-05 | 2 | 139 | 2 | IPR000197 | |
| Domain | KIX | 5.50e-05 | 2 | 139 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 5.50e-05 | 2 | 139 | 2 | PF08214 | |
| Domain | KIX | 5.50e-05 | 2 | 139 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 5.50e-05 | 2 | 139 | 2 | IPR031162 | |
| Domain | DUF902 | 5.50e-05 | 2 | 139 | 2 | PF06001 | |
| Domain | - | 5.50e-05 | 2 | 139 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 5.50e-05 | 2 | 139 | 2 | IPR013178 | |
| Domain | KIX_dom | 5.50e-05 | 2 | 139 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 5.50e-05 | 2 | 139 | 2 | PS51727 | |
| Domain | EGF_Ca-bd_CS | 8.65e-05 | 97 | 139 | 6 | IPR018097 | |
| Domain | EGF_CA | 9.69e-05 | 99 | 139 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.02e-04 | 100 | 139 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.41e-04 | 106 | 139 | 6 | IPR000152 | |
| Domain | EGF_3 | 3.82e-04 | 235 | 139 | 8 | PS50026 | |
| Domain | EGF_CA | 4.56e-04 | 86 | 139 | 5 | PF07645 | |
| Domain | EGF-like_dom | 5.60e-04 | 249 | 139 | 8 | IPR000742 | |
| Domain | EGF_1 | 6.54e-04 | 255 | 139 | 8 | PS00022 | |
| Domain | EGF-like_CS | 7.62e-04 | 261 | 139 | 8 | IPR013032 | |
| Domain | RIH_assoc-dom | 8.09e-04 | 6 | 139 | 2 | IPR013662 | |
| Domain | Nuc_rcpt_coact | 8.09e-04 | 6 | 139 | 2 | IPR009110 | |
| Domain | Ins145_P3_rec | 8.09e-04 | 6 | 139 | 2 | PF08709 | |
| Domain | PEROXIDASE_1 | 8.09e-04 | 6 | 139 | 2 | PS00435 | |
| Domain | RIH_assoc | 8.09e-04 | 6 | 139 | 2 | PF08454 | |
| Domain | RIH_dom | 8.09e-04 | 6 | 139 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.09e-04 | 6 | 139 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.09e-04 | 6 | 139 | 2 | IPR015925 | |
| Domain | - | 8.09e-04 | 6 | 139 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.09e-04 | 6 | 139 | 2 | PF01365 | |
| Domain | EGF_2 | 8.40e-04 | 265 | 139 | 8 | PS01186 | |
| Domain | Channel_four-helix_dom | 8.55e-04 | 57 | 139 | 4 | IPR027359 | |
| Domain | - | 8.55e-04 | 57 | 139 | 4 | 1.20.120.350 | |
| Domain | TB | 1.13e-03 | 7 | 139 | 2 | PF00683 | |
| Domain | Notch_dom | 1.13e-03 | 7 | 139 | 2 | IPR000800 | |
| Domain | Notch | 1.13e-03 | 7 | 139 | 2 | PF00066 | |
| Domain | Hlx-hairpin-Hlx_DNA-bd_motif | 1.13e-03 | 7 | 139 | 2 | IPR003583 | |
| Domain | HhH1 | 1.13e-03 | 7 | 139 | 2 | SM00278 | |
| Domain | NL | 1.13e-03 | 7 | 139 | 2 | SM00004 | |
| Domain | - | 1.50e-03 | 8 | 139 | 2 | 3.90.290.10 | |
| Domain | EGF | 1.91e-03 | 235 | 139 | 7 | SM00181 | |
| Domain | TB_dom | 1.91e-03 | 9 | 139 | 2 | IPR017878 | |
| Domain | TB | 1.91e-03 | 9 | 139 | 2 | PS51364 | |
| Domain | MIR | 2.38e-03 | 10 | 139 | 2 | PF02815 | |
| Domain | An_peroxidase | 2.38e-03 | 10 | 139 | 2 | PF03098 | |
| Domain | MIR_motif | 2.38e-03 | 10 | 139 | 2 | IPR016093 | |
| Domain | Haem_peroxidase_animal | 2.38e-03 | 10 | 139 | 2 | IPR019791 | |
| Domain | MIR | 2.38e-03 | 10 | 139 | 2 | PS50919 | |
| Domain | MIR | 2.38e-03 | 10 | 139 | 2 | SM00472 | |
| Domain | Haem_peroxidase | 2.38e-03 | 10 | 139 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 2.38e-03 | 10 | 139 | 2 | PS50292 | |
| Domain | VDCCAlpha1 | 2.38e-03 | 10 | 139 | 2 | IPR002077 | |
| Domain | - | 2.38e-03 | 10 | 139 | 2 | 1.10.640.10 | |
| Domain | VWFC_1 | 2.41e-03 | 36 | 139 | 3 | PS01208 | |
| Domain | EGF | 2.53e-03 | 126 | 139 | 5 | PF00008 | |
| Domain | VWFC_2 | 2.81e-03 | 38 | 139 | 3 | PS50184 | |
| Domain | VWC | 2.81e-03 | 38 | 139 | 3 | SM00214 | |
| Domain | Ig_I-set | 3.01e-03 | 190 | 139 | 6 | IPR013098 | |
| Domain | I-set | 3.01e-03 | 190 | 139 | 6 | PF07679 | |
| Domain | VWF_dom | 3.75e-03 | 42 | 139 | 3 | IPR001007 | |
| Domain | SAM | 4.23e-03 | 88 | 139 | 4 | SM00454 | |
| Domain | IBR | 4.72e-03 | 14 | 139 | 2 | PF01485 | |
| Domain | IBR | 4.72e-03 | 14 | 139 | 2 | SM00647 | |
| Domain | IBR_dom | 5.42e-03 | 15 | 139 | 2 | IPR002867 | |
| Domain | SAM_DOMAIN | 5.54e-03 | 95 | 139 | 4 | PS50105 | |
| Domain | SAM | 5.97e-03 | 97 | 139 | 4 | IPR001660 | |
| Domain | SANT | 6.12e-03 | 50 | 139 | 3 | SM00717 | |
| Domain | SANT/Myb | 6.83e-03 | 52 | 139 | 3 | IPR001005 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.04e-05 | 6 | 115 | 3 | M22062 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 2.87e-05 | 8 | 115 | 3 | M47850 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.32e-05 | 11 | 115 | 3 | M48021 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SPTLC3 ZNF609 LRRN1 JADE2 PPFIBP2 SEPTIN9 TRPS1 NCAM2 STK32C CREBBP ITPK1 ZNF462 ARRB1 PXDN SHANK2 MEGF6 ZNF608 MICAL2 ANKIB1 PISD SCARA3 NBR1 EP300 EPB41L1 NOTCH3 PCNT | 8.91e-10 | 1489 | 148 | 26 | 28611215 |
| Pubmed | JADE2 TRPS1 APBA1 DEF8 NAP1L1 APC WHAMM NCAM2 TERF1 CREBBP BFSP1 RYR3 ARRB1 FBN1 MICAL2 NISCH CCN2 LTBP3 HERC2 MAP4K4 EP300 PCNT | 2.91e-08 | 1285 | 148 | 22 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAD51 MPP3 HSPG2 LRRK1 STK32C ZDHHC8 SHANK2 MEGF6 LMX1B NISCH PDCD11 AKT1 WDR90 LTBP3 HERC2 SCARA3 ADAT1 EP300 PCNT SYMPK | 5.39e-08 | 1105 | 148 | 20 | 35748872 |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 17015676 | ||
| Pubmed | JADE2 APC STK32C TERF1 CREBBP PPP4R3A ARRB1 TNRC6A NKTR HERC2 MAP3K21 MAP4K4 EP300 | 1.82e-07 | 486 | 148 | 13 | 20936779 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 11481323 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 23285190 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 11940655 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MPO HSPG2 ZSCAN5DP TRPS1 DEF8 BIRC5 CHD7 ITPR1 POP1 FGD1 EP300 | 4.92e-07 | 363 | 148 | 11 | 14691545 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | ZDHHC18 SEPTIN9 NAP1L1 CHD7 ITPK1 ITPR1 ZNF462 TNRC6A FTO MAP4K4 NBR1 EPB41L1 SYMPK | 5.51e-07 | 536 | 148 | 13 | 15840001 |
| Pubmed | ZDHHC18 SEPTIN9 NAP1L1 CHD7 ITPK1 ITPR1 ZNF462 TNRC6A FTO MAP4K4 NBR1 EPB41L1 SYMPK | 5.74e-07 | 538 | 148 | 13 | 10512203 | |
| Pubmed | RAD51 ZNF609 TRPS1 APC CHD7 NUDCD2 PALB2 ZNF462 ZNF608 TNRC6A PCNT | 1.94e-06 | 418 | 148 | 11 | 34709266 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ZNF609 PPFIBP2 APC RBSN SHANK2 ABHD17B TNRC6A FGD1 HERC2 FZD2 MAP4K4 NBR1 EPB41L1 WDR72 | 2.64e-06 | 719 | 148 | 14 | 35337019 |
| Pubmed | ZNF609 JADE2 LRRK1 MAST4 ZNF608 TNRC6A ANKIB1 PDCD11 WDR90 FTO MAP4K4 NBR1 | 3.04e-06 | 529 | 148 | 12 | 14621295 | |
| Pubmed | Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling. | 4.16e-06 | 8 | 148 | 3 | 29170395 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 8.17e-06 | 168 | 148 | 7 | 30631154 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.80e-05 | 2 | 148 | 2 | 34845315 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 1.80e-05 | 2 | 148 | 2 | 26494287 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20717166 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25893291 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11559821 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16889755 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19822209 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.80e-05 | 2 | 148 | 2 | 21847097 | |
| Pubmed | Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. | 1.80e-05 | 2 | 148 | 2 | 15224190 | |
| Pubmed | Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. | 1.80e-05 | 2 | 148 | 2 | 21901101 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.80e-05 | 2 | 148 | 2 | 34813504 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20301699 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 14523021 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 35502657 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31898871 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23097134 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 1.80e-05 | 2 | 148 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 1.80e-05 | 2 | 148 | 2 | 27881443 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 35022238 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30306291 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30953353 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21803292 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 9811832 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24089570 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 1.80e-05 | 2 | 148 | 2 | 39266679 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22303793 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16790529 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 1.80e-05 | 2 | 148 | 2 | 34019788 | |
| Pubmed | Microfibrils at basement membrane zones interact with perlecan via fibrillin-1. | 1.80e-05 | 2 | 148 | 2 | 15657057 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18182168 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 9018065 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32340123 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18794118 | ||
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 1.80e-05 | 2 | 148 | 2 | 29625025 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23986482 | ||
| Pubmed | Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. | 1.80e-05 | 2 | 148 | 2 | 32616814 | |
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.80e-05 | 2 | 148 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.80e-05 | 2 | 148 | 2 | 29170789 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 1.80e-05 | 2 | 148 | 2 | 12646247 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11116148 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11867645 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19081133 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 1.80e-05 | 2 | 148 | 2 | 11963968 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19232344 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12242694 | ||
| Pubmed | Upregulation of FoxO6 in nucleus pulposus cells promotes DNA damage repair via activation of RAD51. | 1.80e-05 | 2 | 148 | 2 | 34533813 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32567731 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31182547 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 1.80e-05 | 2 | 148 | 2 | 27648933 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 10610021 | ||
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 1.80e-05 | 2 | 148 | 2 | 15641773 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 9733868 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32514132 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34506759 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22177454 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17584963 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19729597 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21794903 | ||
| Pubmed | Interaction of human pregnancy-associated plasma protein-A with serine proteinases. | 1.80e-05 | 2 | 148 | 2 | 7586586 | |
| Pubmed | ON pathway mutations increase susceptibility to form-deprivation myopia. | 1.80e-05 | 2 | 148 | 2 | 26072023 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23076336 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 39287984 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28490646 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27007282 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32576962 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24522976 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12811819 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24639469 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 1.80e-05 | 2 | 148 | 2 | 11438528 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 10918613 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17898861 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19272189 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 1.80e-05 | 2 | 148 | 2 | 32690000 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18036246 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15860545 | ||
| Pubmed | Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. | 1.80e-05 | 2 | 148 | 2 | 18829535 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.80e-05 | 2 | 148 | 2 | 24551300 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33911074 | ||
| Interaction | FOXQ1 interactions | 8.37e-06 | 141 | 145 | 8 | int:FOXQ1 | |
| Interaction | TFF1 interactions | 1.09e-05 | 41 | 145 | 5 | int:TFF1 | |
| Interaction | SOX7 interactions | 2.79e-05 | 82 | 145 | 6 | int:SOX7 | |
| Interaction | H2BC3 interactions | RAD51 PABPC4 NAP1L1 GON4L CHD7 NUDCD2 CREBBP PALB2 POP1 AKT1 EP300 KIF22 | 3.86e-05 | 406 | 145 | 12 | int:H2BC3 |
| Interaction | GSC interactions | 3.91e-05 | 87 | 145 | 6 | int:GSC | |
| Interaction | TEAD1 interactions | 4.16e-05 | 176 | 145 | 8 | int:TEAD1 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.33e-06 | 18 | 107 | 4 | 91 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 2.15e-06 | 200 | 148 | 9 | M7839 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-08 | 196 | 148 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-07 | 191 | 148 | 8 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-07 | 191 | 148 | 8 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.91e-07 | 194 | 148 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.91e-07 | 194 | 148 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-07 | 194 | 148 | 8 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-07 | 194 | 148 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.91e-07 | 194 | 148 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.02e-07 | 195 | 148 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-07 | 195 | 148 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.14e-07 | 196 | 148 | 8 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 3.67e-07 | 200 | 148 | 8 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-06 | 164 | 148 | 7 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-06 | 168 | 148 | 7 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-06 | 168 | 148 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-06 | 183 | 148 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-06 | 188 | 148 | 7 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-06 | 188 | 148 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.35e-06 | 189 | 148 | 7 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 3.35e-06 | 189 | 148 | 7 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 189 | 148 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.47e-06 | 190 | 148 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.59e-06 | 191 | 148 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.72e-06 | 192 | 148 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 192 | 148 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.72e-06 | 192 | 148 | 7 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.72e-06 | 192 | 148 | 7 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 193 | 148 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 193 | 148 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.85e-06 | 193 | 148 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.12e-06 | 195 | 148 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 4.12e-06 | 195 | 148 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 196 | 148 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.40e-06 | 197 | 148 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.40e-06 | 197 | 148 | 7 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.55e-06 | 198 | 148 | 7 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 4.70e-06 | 199 | 148 | 7 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 4.70e-06 | 199 | 148 | 7 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.70e-06 | 199 | 148 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 199 | 148 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.60e-06 | 137 | 148 | 6 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.78e-06 | 144 | 148 | 6 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-05 | 164 | 148 | 6 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-05 | 164 | 148 | 6 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-05 | 165 | 148 | 6 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-05 | 165 | 148 | 6 | a5c3af634d2698f9a01cf074791756b7669f9fff | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 166 | 148 | 6 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.97e-05 | 166 | 148 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-05 | 167 | 148 | 6 | 7efa0081e79f22b219eac64ffcaedb2179cde299 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 171 | 148 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 171 | 148 | 6 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 171 | 148 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 175 | 148 | 6 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-05 | 176 | 148 | 6 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 2.74e-05 | 176 | 148 | 6 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 178 | 148 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-05 | 179 | 148 | 6 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.11e-05 | 180 | 148 | 6 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 180 | 148 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.11e-05 | 180 | 148 | 6 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.20e-05 | 181 | 148 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 3.20e-05 | 181 | 148 | 6 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 182 | 148 | 6 | be9c312a44868d4ee266a64d066feb8c5bce5687 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 182 | 148 | 6 | 74dbb706bcaa0f8c922bf3b0424bce5bb27167fa | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-05 | 183 | 148 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-05 | 183 | 148 | 6 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 184 | 148 | 6 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 3.51e-05 | 184 | 148 | 6 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 185 | 148 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 185 | 148 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 185 | 148 | 6 | 239cc5184825b3cc98638d4aec0a1de8e508d76c | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-05 | 185 | 148 | 6 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 186 | 148 | 6 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-05 | 186 | 148 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.84e-05 | 187 | 148 | 6 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 187 | 148 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-05 | 187 | 148 | 6 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.84e-05 | 187 | 148 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.84e-05 | 187 | 148 | 6 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 188 | 148 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-05 | 188 | 148 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 188 | 148 | 6 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.08e-05 | 189 | 148 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-05 | 189 | 148 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.20e-05 | 190 | 148 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.20e-05 | 190 | 148 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-05 | 191 | 148 | 6 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 4.32e-05 | 191 | 148 | 6 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.32e-05 | 191 | 148 | 6 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.32e-05 | 191 | 148 | 6 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| Drug | stattic | 1.45e-06 | 31 | 145 | 5 | ctd:C517409 | |
| Drug | isotetrandrine | 2.93e-06 | 97 | 145 | 7 | CID000005422 | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 4.78e-06 | 196 | 145 | 9 | 2103_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.98e-06 | 197 | 145 | 9 | 4642_DN | |
| Drug | tb-E | 1.21e-05 | 47 | 145 | 5 | CID000006588 | |
| Disease | Prostatic Neoplasms | MPO RNF31 JADE2 PPFIBP2 WNT10B APC BIRC5 CHD7 CREBBP PALB2 ITPR1 EGF AKT1 | 9.39e-06 | 616 | 142 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | MPO RNF31 JADE2 PPFIBP2 WNT10B APC BIRC5 CHD7 CREBBP PALB2 ITPR1 EGF AKT1 | 9.39e-06 | 616 | 142 | 13 | C0376358 |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.30e-05 | 2 | 142 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.30e-05 | 2 | 142 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 2.30e-05 | 2 | 142 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.30e-05 | 2 | 142 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.30e-05 | 2 | 142 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.30e-05 | 2 | 142 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.30e-05 | 2 | 142 | 2 | C0035934 | |
| Disease | Disproportionate short stature | 3.60e-05 | 77 | 142 | 5 | C0878659 | |
| Disease | actinic keratosis | 3.82e-05 | 14 | 142 | 3 | EFO_0002496 | |
| Disease | hip circumference | 4.01e-05 | 338 | 142 | 9 | EFO_0005093 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.53e-05 | 41 | 142 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.53e-05 | 41 | 142 | 4 | C0858252 | |
| Disease | Breast Carcinoma | RAD51 WNT10B BIRC5 PALB2 EGF NISCH AKT1 HERC2 FTO EP300 NOTCH3 | 6.22e-05 | 538 | 142 | 11 | C0678222 |
| Disease | osteoarthritis, hip | 8.45e-05 | 92 | 142 | 5 | EFO_1000786 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.12e-04 | 156 | 142 | 6 | C0007131 | |
| Disease | Congenital stationary night blindness | 1.37e-04 | 4 | 142 | 2 | cv:C0339535 | |
| Disease | Renal glomerular disease | 1.80e-04 | 23 | 142 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.80e-04 | 23 | 142 | 3 | C4521256 | |
| Disease | refractive error | 1.90e-04 | 326 | 142 | 8 | MONDO_0004892 | |
| Disease | Leukemia, Myelocytic, Acute | 1.97e-04 | 173 | 142 | 6 | C0023467 | |
| Disease | hair colour measurement | FOXO6 PPFIBP2 TRPS1 DEF8 PXDN UBE2G2 KRT71 RSPO2 HERC2 FTO EPB41L1 | 2.00e-04 | 615 | 142 | 11 | EFO_0007822 |
| Disease | retinal vasculature measurement | HSPG2 SEPTIN9 ITPR1 KCNA4 PXDN RSPO2 LTBP3 HERC2 GTSCR1 WDR72 | 2.11e-04 | 517 | 142 | 10 | EFO_0010554 |
| Disease | pancreatic cancer (is_implicated_in) | 2.13e-04 | 112 | 142 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 2.28e-04 | 5 | 142 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 2.28e-04 | 5 | 142 | 2 | C0265287 | |
| Disease | Mammary Carcinoma, Human | 2.39e-04 | 525 | 142 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.39e-04 | 525 | 142 | 10 | C1257931 | |
| Disease | Drugs used in diabetes use measurement | 2.45e-04 | 255 | 142 | 7 | EFO_0009924 | |
| Disease | Mammary Neoplasms | 2.46e-04 | 527 | 142 | 10 | C1458155 | |
| Disease | Carcinoma, Granular Cell | 2.51e-04 | 116 | 142 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.51e-04 | 116 | 142 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.51e-04 | 116 | 142 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.51e-04 | 116 | 142 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.51e-04 | 116 | 142 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 2.51e-04 | 116 | 142 | 5 | C0001418 | |
| Disease | Colorectal cancer | 2.93e-04 | 27 | 142 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.93e-04 | 27 | 142 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.93e-04 | 27 | 142 | 3 | cv:C0009404 | |
| Disease | Malignant tumor of breast | 2.93e-04 | 27 | 142 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.93e-04 | 27 | 142 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 2.93e-04 | 27 | 142 | 3 | cv:C0346153 | |
| Disease | sexual dimorphism measurement | FOXO6 KCTD19 PABPC4 TRPS1 APC SNAP47 ZNF462 FBN1 ZNF608 TNRC6A PAPPA LTBP3 FTO SPOCD1 EPB41L1 | 2.97e-04 | 1106 | 142 | 15 | EFO_0021796 |
| Disease | Lung Neoplasms | 3.09e-04 | 265 | 142 | 7 | C0024121 | |
| Disease | squamous cell carcinoma | 3.11e-04 | 67 | 142 | 4 | EFO_0000707 | |
| Disease | Malignant neoplasm of lung | 3.16e-04 | 266 | 142 | 7 | C0242379 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 3.41e-04 | 6 | 142 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Squamous cell carcinoma | 3.42e-04 | 124 | 142 | 5 | C0007137 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.75e-04 | 195 | 142 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Rectal Neoplasms | 4.75e-04 | 7 | 142 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 4.75e-04 | 7 | 142 | 2 | C0007113 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 4.89e-04 | 32 | 142 | 3 | EFO_0000341, EFO_0004325 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.01e-04 | 206 | 142 | 6 | C0152013 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 6.32e-04 | 8 | 142 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 6.32e-04 | 8 | 142 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 6.32e-04 | 8 | 142 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 6.32e-04 | 8 | 142 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 6.32e-04 | 8 | 142 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 6.32e-04 | 8 | 142 | 2 | C0393703 | |
| Disease | Malignant neoplasm of breast | RAD51 WNT10B BIRC5 GRM6 PALB2 EGF NISCH POP1 AKT1 HERC2 FTO SPOCD1 EP300 NOTCH3 | 7.01e-04 | 1074 | 142 | 14 | C0006142 |
| Disease | Myoclonic Epilepsy | 8.10e-04 | 9 | 142 | 2 | C0014550 | |
| Disease | Craniofacial Abnormalities | 9.70e-04 | 156 | 142 | 5 | C0376634 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.01e-03 | 10 | 142 | 2 | C0917800 | |
| Disease | neutrophil count | MPO ZDHHC18 JADE2 SEPTIN9 PCDHA8 CD46 CHD7 TEX14 PSPH CREBBP MICAL2 TNRC6A AKT1 FTO MAP4K4 PCNT | 1.03e-03 | 1382 | 142 | 16 | EFO_0004833 |
| Disease | body surface area | 1.14e-03 | 643 | 142 | 10 | EFO_0022196 | |
| Disease | Myoclonic Astatic Epilepsy | 1.23e-03 | 11 | 142 | 2 | C0393702 | |
| Disease | high density lipoprotein particle size measurement | 1.42e-03 | 170 | 142 | 5 | EFO_0008592 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.47e-03 | 12 | 142 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.47e-03 | 12 | 142 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.47e-03 | 12 | 142 | 2 | C1864877 | |
| Disease | stenosing tenosynovitis | 1.47e-03 | 12 | 142 | 2 | EFO_0010822 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.47e-03 | 12 | 142 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.47e-03 | 12 | 142 | 2 | C3711543 | |
| Disease | Intestinal Neoplasms | 1.47e-03 | 12 | 142 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 1.47e-03 | 12 | 142 | 2 | C0346627 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.47e-03 | 12 | 142 | 2 | C1848172 | |
| Disease | amino acid measurement | 1.69e-03 | 678 | 142 | 10 | EFO_0005134 | |
| Disease | Benign tumor of pancreas | 1.73e-03 | 13 | 142 | 2 | C0347284 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.73e-03 | 13 | 142 | 2 | C0751122 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.73e-03 | 13 | 142 | 2 | C4041558 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.73e-03 | 13 | 142 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | eosinophil measurement | 1.87e-03 | 108 | 142 | 4 | EFO_0803540 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.87e-03 | 181 | 142 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Hypodontia | 2.01e-03 | 14 | 142 | 2 | C0020608 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.01e-03 | 14 | 142 | 2 | C0677776 | |
| Disease | basal cell carcinoma | 2.26e-03 | 189 | 142 | 5 | EFO_0004193 | |
| Disease | macula measurement | 2.26e-03 | 189 | 142 | 5 | EFO_0008375 | |
| Disease | Small cell carcinoma of lung | 2.26e-03 | 54 | 142 | 3 | C0149925 | |
| Disease | N-acetylmethionine measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0021427 | |
| Disease | clonal hematopoiesis mutation measurement | 2.38e-03 | 55 | 142 | 3 | EFO_0020949 | |
| Disease | keratinocyte carcinoma | 2.58e-03 | 118 | 142 | 4 | EFO_0010176 | |
| Disease | T-Cell Lymphoma | 2.64e-03 | 16 | 142 | 2 | C0079772 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.64e-03 | 16 | 142 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Polyposis, Adenomatous Intestinal | 2.64e-03 | 16 | 142 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.64e-03 | 16 | 142 | 2 | C2713443 | |
| Disease | pain | 2.64e-03 | 196 | 142 | 5 | EFO_0003843 | |
| Disease | colorectal cancer (is_implicated_in) | 2.83e-03 | 121 | 142 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | metabolic syndrome | 2.88e-03 | 200 | 142 | 5 | EFO_0000195 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFLEGCACTPERMAE | 26 | O15392 | |
| PPDQDDSMECVDSER | 451 | P31749 | |
| DSMECVDSERRPHFP | 456 | P31749 | |
| DPLIPCDLMDGRDAF | 1616 | Q09472 | |
| RDETFVQDGSMCGPD | 321 | Q6NVV9 | |
| EQFPGEMFPVACRET | 626 | Q8NI51 | |
| CMEGRGIPAPEEERT | 301 | O95433 | |
| SCSQMPAFSEPAGEE | 666 | Q86TB3 | |
| IDSDDTQFPPMRCGL | 161 | O43506 | |
| FTECGNAMERDPLEA | 1106 | P51816 | |
| MLDQPGFPDCSIEAA | 366 | Q9H845 | |
| ASPEPSADEDDLMTC | 651 | C9J069 | |
| DPDPLLSCDLMDGRD | 1651 | Q92793 | |
| LMSPGSCLEDFRAAP | 1616 | P53420 | |
| SVFEDPVDMPCGHDF | 341 | Q9P2G1 | |
| TGPPGDMFSLDECRS | 531 | Q6MZZ7 | |
| EGFIARMCSPSPDAT | 646 | Q5JTW2 | |
| CNDAFVEVGMPRSPS | 621 | Q9H694 | |
| RASAPAEPDSACCME | 11 | Q6ZP65 | |
| ADPALCFLERVGMPD | 1811 | Q9P2D1 | |
| AMPEPESLRAFDSDG | 466 | O75071 | |
| CPVAMEEADDTVAPS | 251 | P49407 | |
| PCGDASIIPMLEFED | 141 | Q9BUB4 | |
| ESDCPDRSDEFGCMP | 391 | P98160 | |
| DRSDEFGCMPPQVVT | 396 | P98160 | |
| FEEPTCINPFEMDSD | 711 | Q9H1K0 | |
| CINPFEMDSDSGPEA | 716 | Q9H1K0 | |
| DSPCLPEAEAMFAIN | 316 | Q06609 | |
| DSDPFSFDGPEIMGC | 241 | P55209 | |
| RFDDMSSPGLELPSC | 121 | Q6IN85 | |
| PPVVGSDGFCMFFED | 766 | Q17RG1 | |
| MEPTRDCPLFGGAFS | 1 | Q9HD47 | |
| DCRSPGIGLVEEPMD | 171 | Q8NG50 | |
| GSDMEAEEDPSPCAS | 271 | O60840 | |
| LPEGRALPVFCDMDT | 111 | O75636 | |
| EGFPSPPDFILMADC | 131 | Q9H867 | |
| APTGSECPDRLAMDF | 466 | Q13310 | |
| EDSPDRGACSTPDMP | 676 | Q9H4G0 | |
| FSCDGMRPEAIRQDP | 881 | O95819 | |
| RMPDSRFPLEGASDA | 146 | Q9Y5H6 | |
| EDDRICSPPFMELTS | 121 | Q13572 | |
| CSPPFMELTSLCGDD | 126 | Q13572 | |
| FSDACEEPPTFEAME | 31 | P15529 | |
| MSAPFEERSGVVPCG | 1 | Q8WVJ2 | |
| PFTDCGDGPMLRLEE | 526 | Q14643 | |
| GPEESAVCPERAMET | 16 | Q38SD2 | |
| CPCIPMFDLEGSLDE | 4361 | O95714 | |
| DAVPLCMSADFPRVG | 166 | Q9C0B1 | |
| RSPEGEDGNEMVFCD | 206 | Q9NQC1 | |
| TSCSPGFELMEAPGE | 4971 | Q02817 | |
| SDPPCVRGMDSCSLE | 61 | Q14807 | |
| IPCFLAGDTRSSEMP | 396 | P05164 | |
| RSPFADGETPDICMD | 241 | P34910 | |
| DMPESEECASAPAPV | 521 | Q8TEB1 | |
| EPARPDGSMFFSQEE | 226 | Q14332 | |
| EDCGPERRATAPAMA | 51 | A8MYZ6 | |
| ASFCGGALEPMPTEE | 1796 | Q9UM47 | |
| VCFPGGKRDPTDMDD | 71 | P0C024 | |
| PCMETEPSFETGDLC | 586 | Q13219 | |
| CRFEMEGLPVDESDS | 101 | Q02509 | |
| AAMLADFIDCPPDDE | 1106 | Q8IZL8 | |
| SFLMSPESVRECEQP | 1241 | O95613 | |
| ESTDYICPMEPSDGV | 831 | Q8ND30 | |
| EGEESPPAICMEVFL | 66 | Q86UQ5 | |
| VAPDDNDRPTTDMCS | 711 | Q86YC2 | |
| GDFPDCPAGMLFAEE | 661 | Q99575 | |
| PATEEPGESFCDKVM | 141 | P24001 | |
| DEFTCEACPGDMRPT | 551 | O15303 | |
| PDMCFVELPGVEFRA | 241 | A0AVK6 | |
| RRPADTEDGMSSCPQ | 1081 | P01133 | |
| TVAPEMCPIRATEDF | 371 | P35555 | |
| DTFGPDPTMIRANCL | 186 | P29279 | |
| EPAECVEFTAEPAGM | 166 | F2Z333 | |
| DEESRRPCAMVTPGA | 566 | Q12934 | |
| STAVSPDPENFLCEM | 1911 | Q9P0X4 | |
| LMDPISDPEFFGSCK | 3556 | Q8WXX0 | |
| EELASSPVCMDSFQP | 471 | Q3T8J9 | |
| SPTRDCDDQRPMDGD | 386 | Q02410 | |
| EDYMSDLRCGDPENP | 21 | Q9Y6X4 | |
| MDVDECQDPAACRPG | 1081 | Q9NS15 | |
| FGNFPEPDMCVGESV | 276 | Q6MZM0 | |
| DTCREPSMELCFPET | 1991 | O15021 | |
| GEPEFRCPERVMDLG | 111 | Q6ZN54 | |
| MPACAASSLPRVDDV | 641 | Q92503 | |
| TAFPDGRSSFCGEMP | 121 | Q8IY34 | |
| AGDDEDMPTFPCTQK | 21 | Q6AZY7 | |
| RCSSFMAPPVTDLGE | 126 | P36551 | |
| TFKFLPASEPCEMDD | 651 | Q9C0B2 | |
| PASEPCEMDDSQSAL | 656 | Q9C0B2 | |
| GDAESSEMQRPPPDC | 776 | P20273 | |
| DAESRQEVPMCTGPE | 346 | Q96EK7 | |
| TTVFLDCRAMAEPEP | 441 | Q6UXK5 | |
| SDPAEMTSDECQPAE | 1366 | O94851 | |
| MSPACEDTAAPFDEQ | 516 | Q13368 | |
| EDRRGCSPLEEPMVD | 446 | O75095 | |
| FLEGFPCSPRLDEMS | 66 | Q9HBX3 | |
| FMACSPVALDESDPD | 26 | P35716 | |
| DAPCPAPFMAEEASS | 601 | Q8IWB6 | |
| ARMCISGFDEPVPDL | 471 | Q7Z6J9 | |
| EMPFITCDEFNGVPS | 136 | Q96BD8 | |
| KPREDVSMTSCEPFG | 236 | Q5SQN1 | |
| GREPALMPRLDTDCS | 846 | Q5TCX8 | |
| DDNMEICTPDRSSPA | 1126 | P30414 | |
| LPECFDTSRPLGDSM | 736 | Q14596 | |
| CPGPTLSEDREMEEA | 926 | P98174 | |
| SEEPSGRKESQEMCP | 6 | Q6PI97 | |
| MEEPQAGDAARFSCP | 1 | O15446 | |
| AEAEPMNSDEPEACF | 1141 | Q15858 | |
| PSCVGDMADTPRDAG | 246 | Q9UHD8 | |
| RPRDSLESFSCPGSM | 696 | Q8TF30 | |
| CSAPGPLFDLMERVS | 131 | Q9NUV7 | |
| PDVETPSEEDCMFGN | 471 | P00747 | |
| SAMPACLSDVESDPR | 171 | Q15319 | |
| DECPDGFAPLEETME | 126 | Q6UXX9 | |
| PEGFMGLDCRERVPD | 456 | Q8TER0 | |
| TRPSMFPEEGDFADE | 1121 | Q9UPX8 | |
| DEAERSALPMCGPIC | 466 | Q86UX6 | |
| PDPTYTLMCDESGSR | 31 | Q5VST6 | |
| SFTPGDDMPRVYCVE | 1631 | P25054 | |
| DTDADSCPLMAEENP | 471 | Q14028 | |
| PGPEDNRSHCDYMES | 116 | Q8TEF2 | |
| DMVCPACGRPDLTDD | 741 | Q96EP0 | |
| MDPGRQPESADDFDR | 1596 | Q14690 | |
| AEADDPQDMACTPSG | 131 | Q9UHF7 | |
| VDMECQTDAFLDRPP | 271 | Q86UC2 | |
| ARDGCPEPSAAMLFV | 561 | Q96KV7 | |
| MASAGGEDCESPAPE | 1 | Q9HA47 | |
| KAGRRMFSCPEESDP | 41 | P0CG00 | |
| MFSCPEESDPIQALR | 46 | P0CG00 | |
| APEECRSFMSGRPSQ | 996 | Q8N2C7 | |
| EEMTFSCRASGSPEP | 226 | O15394 | |
| ATDMEACPPADAFIG | 181 | P78330 | |
| DPCMSLSPPCFTEED | 51 | Q9P246 | |
| DAPFTTCPEGPARDM | 421 | Q8IZW8 | |
| GSVSEPDMAANFCPD | 2346 | Q15413 | |
| LDTEASRACSGPFME | 401 | Q6ZMY3 | |
| DPACSQSGPMEAEED | 571 | Q6ZMY3 | |
| ESFLGPRMCTEDLPF | 216 | Q9UG56 | |
| MATARTFGPEREAEP | 1 | Q9Y2I1 | |
| FATGPPTECMRDENE | 951 | Q92626 | |
| APPRFCDSPTSDLEM | 351 | O15014 | |
| DMPDRCALEESESPG | 1071 | Q3MJ13 | |
| MAEDVSSAAPSPRGC | 1 | P54274 | |
| PECETPGIFISMDDD | 1196 | Q92797 | |
| PRFCESPTSDLEMRG | 416 | Q9ULD9 | |
| SERDGPPVENEMFFC | 1181 | Q96JM2 | |
| TFMDPGVFPRADEDE | 66 | Q9ULC8 | |
| FEKSPDFCERDPTMG | 311 | O00744 | |
| DFCERDPTMGSPGTR | 316 | O00744 | |
| PETCPFFEEMDALVS | 481 | Q8IWY8 | |
| SAPGSDPELASECMD | 241 | Q8NDV7 | |
| DEPACRAKPDASMVG | 371 | Q9NUE0 | |
| IMGPEDTCFEFGVFP | 41 | P60604 | |
| SFPHCSDLMPSGSEE | 101 | P22459 | |
| LESEECRMSGEFPSP | 436 | Q3SY84 | |
| MDIATGPESLERCFP | 1 | O60663 |